Cargando…
Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed
Mycobacterium tuberculosis, the cause of Tuberculosis (TB), infects one third of the world’s population and causes substantial mortality worldwide. In its shortest format, treatment of TB requires six months of multidrug therapy with a mixture of broad spectrum and mycobacterial specific antibiotics...
Autores principales: | Wipperman, Matthew F., Fitzgerald, Daniel W., Juste, Marc Antoine Jean, Taur, Ying, Namasivayam, Sivaranjani, Sher, Alan, Bean, James M., Bucci, Vanni, Glickman, Michael S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589918/ https://www.ncbi.nlm.nih.gov/pubmed/28883399 http://dx.doi.org/10.1038/s41598-017-10346-6 |
Ejemplares similares
-
The Microbiome and Tuberculosis: Early Evidence for Cross Talk
por: Namasivayam, Sivaranjani, et al.
Publicado: (2018) -
Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy
por: Namasivayam, Sivaranjani, et al.
Publicado: (2017) -
The Dysbiosis Triggered by First-Line Tuberculosis Antibiotics Fails to Reduce Their Bioavailability
por: Namasivayam, Sivaranjani, et al.
Publicado: (2023) -
Gastrointestinal microbiota composition predicts peripheral inflammatory state during treatment of human tuberculosis
por: Wipperman, Matthew F., et al.
Publicado: (2021) -
Enhancement of CD4(+) T Cell Function as a Strategy for Improving Antibiotic Therapy Efficacy in Tuberculosis: Does It Work?
por: Costa, Diego L., et al.
Publicado: (2021)